GE Healthcare invests $80M to expand contrast media API capacity in Norway

GE Healthcare's Pharmaceutical Diagnostics business announced an $80 million investment to increase manufacturing capacity by 30% at its Active Pharmaceutical Ingredients site in Lindesnes, Norway, creating about 100 new jobs. The expansion aims to enable production of 30 million more patient doses per year by 2025.

“This investment in capacity expansion at our Lindesnes facility is another example of how we, as an industry leader, are addressing this growing demand to meet the needs of our customers and their patients across the globe.”businesswire.com

• 2 sources
• businesswire.comGE Healthcare Announces $80 Million Investment To Expand Contrast Media Production CapacityMedia ContactNov 17, 2022
• appliedradiology.comGE to Invest $80 Million to Expand Contrast Media ...News ReleaseNov 18, 2022

Summarized from public sources; check the original articles before acting on it.